A. C. White

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement.

N. Svrzikapa, G. Shapiro, P. LoRusso, 2013, Cancer discovery.

3'-Modification stabilizes mRNA and increases translation in cells.

F. Zécri, A. C. White, J. Diener, 2018, Bioorganic & medicinal chemistry letters.

siRNA in vitro and in vivo Comprehensive evaluation of canonical versus Dicer-substrate Material Supplemental

M. Manoharan, S. Elbashir, G. Hinkle, 2012 .

Mir-290–295 deficiency in mice results in partially penetrant embryonic lethality and germ cell defects

P. Sharp, D. Page, R. Jaenisch, 2011, Proceedings of the National Academy of Sciences.